Structural and Functional Remodeling and Long-Term Outcomes in Women With Hypertrophic Cardiomyopathy
Hala Mahfouz Badran1,2, Abdelmaguid Ma Abu Hagar1, Naglaa Faheem1
1Cardiology Department, Menoufia University, Shibin El Kom, Egypt.
Echocardiography (Mount Kisco, N.Y.)
|April 21, 2026
Summary
Women with hypertrophic cardiomyopathy (HCM) have smaller hearts, higher filling pressures, and impaired myocardial deformation. These distinct features in women with HCM are linked to increased hospitalizations, necessitating sex-specific management.
Area of Science:
- Cardiology
- Cardiovascular Research
- Medical Science
Background:
- Sex-related differences in hypertrophic cardiomyopathy (HCM) are increasingly recognized.
- Women are underrepresented in most HCM cohorts, limiting understanding of sex-specific characteristics.
- This study addresses the need to characterize sex-specific differences in HCM.
Purpose of the Study:
- To characterize sex-specific differences in clinical features of HCM.
- To investigate sex-specific differences in myocardial mechanics.
- To analyze sex-specific long-term outcomes in patients with HCM.
Main Methods:
- A cohort of 501 patients with HCM was evaluated.
- 181 (36%) of the patients were women.
- Comprehensive clinical and echocardiographic data were collected, with survival and event-free outcomes assessed over a median follow-up of 6.23 years.
Main Results:
- Women with HCM had smaller left ventricular (LV) dimensions and lower LV mass index (LVMI) compared to men.
- Women exhibited higher E/E' ratio, increased pulmonary artery systolic pressure, reduced global longitudinal strain (GLS), and lower early diastolic strain rate (SRe).
- Hospitalizations for heart failure, arrhythmias, or stroke were more frequent in women (34.4% vs. 24.4%), despite women being less symptomatic.
Conclusions:
- Women with HCM display distinct structural and mechanical features, including smaller ventricular size, lower LV mass, higher filling pressures, and impaired myocardial deformation.
- These sex-specific differences are associated with increased morbidity.
- The findings support the need for sex-specific diagnostic thresholds and individualized management strategies for women with HCM.
Related Concept Videos
Heart Failure II: Pathophysiology
1.4K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Cardiomyopathy V: Interprofessional Care
743
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743
Cardiomyopathy III: Hypertrophic Cardiomyopathy
795
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
795
Pathophysiology of Heart Failure
4.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Cardiomyopathy II: Dilated Cardiomyopathy
767
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
767
Cardiomyopathy IV: Restrictive Cardiomyopathy
930
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
930


